Zimmer Biomet Holdings (ZBH) said Monday it has received the CE Mark for its Persona Revision Knee System, which aims to provide a personalized fit and optimized function for patients going through revision knee surgery.
Wilfred van Zuilen, the company's group president for Europe, Middle East and Africa, said the the introduction of the system will expand the company's knee portfolio.
Price: 113.33, Change: +3.39, Percent Change: +3.08
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments